Search
for
Sort by
Research 421–450 of 1000+
- Gut microbiota-derived metabolites in keloid and hypertrophic scarring
- Identifying effective immune biomarkers in alopecia areata diagnosis based on machine learning methods
- Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
- The Role of the Microbiome in the Resolution of Infection-Induced Inflammation
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- Dynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- Utilization of Stem Cells in Medicine: A Narrative Review
- Recent Advances in Drug Development for Hair Loss
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Exosomal microRNA-Based therapies for skin diseases
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- An essential role for <i>Rxrα</i> in the development of Th2 responses
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- Pinkie, the First Viable Germline Hypomorph Allele of Retinoid X Receptor Alpha, Reveals an Important Role for RXRa in Th2 Development.
- The effect of 5-α reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
- Influence of Gushen Shengfa Pills Combined Wuling Capsules on Th1/Th2 Cytokines in Patients with Alopecia Areata Disease
- 0085 Th1/Th2 balance, IFN-γ–MHC-I axis, and regulatory T cells define therapeutic response endotypes in alopecia areata